Medgenics, Inc. Extends Collaboration with Baxter Healthcare Corporation on Development of Factor VIII Biopump

July 6, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MISGAV, Israel and VIENNA, Va.--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) announces an extension of its agreement with Baxter Healthcare Corporation for the joint development of the Factor VIII Biopump.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia